• Back to miR-31-5p

• Kim S, Lee KS, Choi S, Kim J, Lee DK, Park M, Park W, Kim TH, Hwang JY, Won MH, Lee H, Ryoo S, Ha KS, Kwon YG, Kim YM. NF-κB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase. J Biol Chem. 2018 Dec 7;293(49):18989-19000. doi: 10.1074/jbc.RA118.005197. Epub 2018 Oct 2. PMID: 30279269; PMCID: PMC6295733. See more on PubMed
• Lei SL, Zhao H, Yao HL, Chen Y, Lei ZD, Liu KJ, Yang Q. Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells. Oncol Lett. 2014 Oct;8(4):1768-1774. doi: 10.3892/ol.2014.2328. Epub 2014 Jul 9. PMID: 25202407; PMCID: PMC4156175. See more on PubMed
• Li Y, Quan J, Chen F, Pan X, Zhuang C, Xiong T, Zhuang C, Li J, Huang X, Ye J, Zhang F, Zhang Z, Gui Y. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1). Biomed Pharmacother. 2019 Mar;111:517-526. doi: 10.1016/j.biopha.2018.12.102. Epub 2018 Dec 28. PMID: 30597305. See more on PubMed
• Lu Z, He Q, Liang J, Li W, Su Q, Chen Z, Wan Q, Zhou X, Cao L, Sun J, Wu Y, Liu L, Wu X, Hou J, Lian K, Wang A. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer. Mol Ther Nucleic Acids. 2019 Jun 7;16:471-480. doi: 10.1016/j.omtn.2019.03.012. Epub 2019 Apr 11. PMID: 31051332; PMCID: PMC6495075. See more on PubMed
• Yi SJ, Liu P, Chen BL, Ou-Yang L, Xiong WM, Su JP. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma. Neoplasma. 2019 May 11;2019:181109N847. PMID: 31088103. See more on PubMed